Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.82 USD | -1.31% | 0.00% | +19.67% |
06-24 | Generali buys back own shares for approximately EUR33 million | AN |
06-21 | Generali Seeks to Sell Units in Turkey and Philippines | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- With a P/E ratio at 9.44 for the current year and 8.69 for next year, earnings multiples are highly attractive compared with competitors.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.84 for the current period. Therefore, the company is undervalued.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+19.67% | 38.54B | - | ||
+3.66% | 72.1B | B- | ||
+8.25% | 50.75B | B | ||
+6.14% | 49.91B | B+ | ||
+24.42% | 47.64B | B+ | ||
+13.00% | 42.08B | B+ | ||
+17.16% | 33.02B | B | ||
-2.39% | 28.42B | B | ||
-9.01% | 27.19B | B- | ||
+28.96% | 26.64B | A |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- G Stock
- ARZGF Stock
- Ratings Generali